Cefotaxime as the potential cause of transient acquired von Willebrand syndrome

Haj, M. A., Murch, N., Bowen, Derrick John, Sati, H. I., Beddal, A., Benton, A. and Collins, Peter William ORCID: https://orcid.org/0000-0002-6410-1324 2006. Cefotaxime as the potential cause of transient acquired von Willebrand syndrome. European Journal of Haematology 76 (5) , pp. 440-443. 10.1111/j.0902-4441.2006.t01-1-EJH2386.x

Full text not available from this repository.

Abstract

Acquired von Willebrand syndrome (AvWS) is a relatively rare bleeding disorder. It has been reported in association with myeloproliferative disorders, autoimmune diseases, plasma cell dyscrasias and certain drugs. Cefotaxime is a third generation cephalosporin widely used for surgical prophylaxis and as empirical treatment of bacterial meningitis. We report a case of a transient AvWS in association with cefotaxime therapy.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine Systems Immunity Research Institute (SIURI)
Subjects:	R Medicine > R Medicine (General)
Uncontrolled Keywords:	acquired; von Willebrand syndrome; cefotaxime
Publisher:	Wiley-Blackwell
ISSN:	0902-4441
Last Modified:	04 Jan 2023 02:13
URI:	https://orca.cardiff.ac.uk/id/eprint/57558

Citation Data

Cited 4 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item